# AstraZeneca (Japan)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/astrazeneca-japan/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 51.8 |
| Citations | 187,968 |
| City | Osaka |
| Country | JP |
| Description | AstraZeneca (Japan) is a research organisation in Osaka, JP. OpenAlex records 1,877 works and 187,968 citations for it. 833 researchers list it as their most recent affiliation. |
| Homepage | https://www.astrazeneca.co.jp/ |
| OpenAlex ID | https://openalex.org/I4210128490 |
| Researchers | 833 |
| ROR ID | https://ror.org/047k23798 |
| Type | company |
| Works | 1,877 |

## University papers

Showing 12 of 20.

- [The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers](https://scholariq.org/papers/the-genomic-landscape-of-endocrine-resistant-advanced-breast-cancers/)
- [Ionic immune suppression within the tumour microenvironment limits T cell effector function](https://scholariq.org/papers/ionic-immune-suppression-within-the-tumour-microenvironment-limits-t-cell/)
- [Non–Small Cell Lung Cancer, Version 6.2015](https://scholariq.org/papers/non-small-cell-lung-cancer-version-6-2015/)
- [Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases](https://scholariq.org/papers/discovery-of-a-first-in-class-receptor-interacting-protein-1-rip1-kinase/)
- [PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer](https://scholariq.org/papers/pi3k-inhibition-results-in-enhanced-estrogen-receptor-function-and-dependence-in/)
- [Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer](https://scholariq.org/papers/randomized-double-blind-phase-ii-study-of-temozolomide-in-combination-with/)
- [Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy](https://scholariq.org/papers/mitochondrial-membrane-potential-identifies-cells-with-enhanced-stemness-for/)
- [HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers](https://scholariq.org/papers/her2-mediated-internalization-of-cytotoxic-agents-in-i-erbb2-i-amplified-or/)
- [DNA-Encoded Library Screening Identifies Benzo\[<i>b</i>\]\[1,4\]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors](https://scholariq.org/papers/dna-encoded-library-screening-identifies-benzo-i-b-i-1-4-oxazepin-4-ones-as/)
- [Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and <i>P16/CDKN2A</i> Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction](https://scholariq.org/papers/global-gene-expression-profiling-of-pleural-mesotheliomas-overexpression-of/)
- [Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes](https://scholariq.org/papers/small-cell-lung-cancers-in-patients-who-never-smoked-cigarettes/)
- [Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis](https://scholariq.org/papers/discovery-of-small-molecule-rip1-kinase-inhibitors-for-the-treatment-of/)

## University researchers

- [Christina Pao](https://scholariq.org/researchers/christina-pao/)

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.